Press Releases on May 14, 2024 - EIN Presswire - Press Release Distribution Service

Published on May 14, 2024 - 20:05 GMT

QIAGEN erhält europäische IVDR-Zertifizierung für seine Medizinprodukte-Software zur Unterstützung der klinischen ...

VENLO, Niederlande, May 14, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute bekannt gegeben, dass eine aktualisierte Version von QIAGEN Clinical Insight Interpret die EU-Zertifizierung über die Bewertung der …

Distribution channels: Media, Advertising & PR, Technology ...

Published on May 14, 2024 - 20:05 GMT

Robinhood Markets, Inc. to Present at the J.P. Morgan Global Technology, Media and Communications Conference on May 21, 2024

MENLO PARK, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming J.P. Morgan Global Technology, Media and Communications Conference on Tuesday, May 21, …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on May 14, 2024 - 20:05 GMT

Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference

FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update

Announced positive proof of concept data from Phase 1 clinical trial of ELVN-001 in CML, achieving an initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients Strong balance sheet with $321 million in cash, cash equivalents and …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

VirTra Reports First Quarter 2024 Financial Results

VirTra Advances Preparations for V-XR Deliveries Strategic Military Training Initiatives Position Company for Continued Market Penetration CHANDLER, Ariz., May 14, 2024 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024

RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced its operating and financial results for the first quarter 2024. …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Jones Soda Reports First Quarter 2024 Results

SEATTLE, May 14, 2024 (GLOBE NEWSWIRE) -- Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), a beverage innovation company focused on developing, marketing and distributing cutting edge consumer drink and wellness products and a …

Distribution channels: Business & Economy, Food & Beverage Industry ...

Published on May 14, 2024 - 20:05 GMT

SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update

- Announced Independent Data Monitoring Committee’s (IDMC) Recommendation to Continue the Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Without Modifications: IDMC to Reconvene in June - - Completed Enrollment in Phase 3 REGAL Study of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 14, 2024 - 20:05 GMT

Iridex Reports First Quarter 2024 Financial Results

MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update

Phase 2b clinical trial evaluating Lomecel-BTM in rare pediatric disease HLHS on track for completing enrollment by end of 2024 Data from Phase 2a clinical trial evaluating Lomecel-BTM in Alzheimer’s Disease selected for Featured Research Oral Presentation …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Atea Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Full Enrollment Achieved in Global Phase 3 SUNRISE-3 Trial for Treatment of COVID-19 with Results Expected 2H’24 Global Phase 2 HCV Study On Track to Report Complete SVR12 Results 2H’24 Multiple Presentations Showcasing Preclinical and New Phase 2 Efficacy …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Fiverr to Present at Upcoming Conference

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Fiverr International Ltd, (NYSE: FVRR), the company that is changing how the world works together, today announced that Micha Kaufman, Founder and Chief Executive Officer, and Ofer Katz, President and Chief …

Distribution channels: Business & Economy, Companies ...

Published on May 14, 2024 - 20:05 GMT

iPower Reports Fiscal Third Quarter 2024 Results

Fiscal Q3 Revenue up 15% to $23.3 Million Driven In-Part by Accelerated Growth of iPower SuperSuite Business Gross Margin Expansion and Improved Operating Leverage Enables Return to Profitability Strong Fiscal Q3 Performance Lays Foundation for Further …

Distribution channels: Business & Economy, IT Industry ...

Published on May 14, 2024 - 20:05 GMT

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Initial Data from Ongoing MyPEAK™-1 Phase 1b of TN-201 Expected in Second Half of 2024 Clinical Sites Activated for RIDGE™-1 Phase 1b Clinical Trial of TN-401 Announced Cost Containment Measures in Alignment with Focus on Generating Data from Clinical- …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational development program in Hemophilia A; development candidate nomination anticipated in mid-year 2024; 12-month non-human primate durability data expected in …

Distribution channels: Business & Economy, Technology ...

Published on May 14, 2024 - 20:05 GMT

GEN Restaurant Group, Inc. Announces First Quarter 2024 Financial Results

CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”), owner of GEN Korean BBQ, a fast-growing cook-it-yourself casual dining concept, is announcing financial results for the first quarter ended March 31, …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

HUNTSVILLE, May 14, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today reported financial results for the quarter …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

Vivos Expanding its Revenue Generating Initiatives As Operating Expenses Decrease 22%, Representing Seven Consecutive Quarters of Year Over Year Improvement Due to Successful Cost Cutting Initiatives Management to Host Conference Call Today at 5:00 pm ET …

Distribution channels:

Published on May 14, 2024 - 20:05 GMT

CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

- 26 sites activated and over 20 patients dosed in the potentially pivotal Phase 2 clinical study, FIRCE-1 of firicabtagene autoleucel (firi-cel) (CRG-022); Currently on-track for interim results expected in 1H25 - - Independent Data Monitoring Committee ( …

Distribution channels: